Abstract: The present invention is directed to processes for extracting IgG from an unused waste precipitate produced during normal plasma fractionation processes via a separate fractionation process, thereby increasing the overall yield of IgG from blood plasma.
Abstract: Methods for preparing Factor X, activated Factor X, inactivated factor X and inactivated factor Xa, compositions comprising Factor X and Factor Xa, inactivated Factor X and inactivated Factor Xa and methods of medical treatment using Factor X, Factor Xa, activated Factor X and inactivated Factor Xa are disclosed. The preparation methods comprise a chromatography step using an immobilised metal ion affinity chromatography substrate.
Abstract: The invention provides a method for the isolation of haptoglobin from a sample comprising Cohn fraction V, wherein said method comprises anion exchange chromatography of said sample. The product may be further purified and/or subjected to one or more virus inactivation or reduction steps. The isolated haptoglobin may then be formulated for pharmaceutical use.
Type:
Grant
Filed:
October 19, 2005
Date of Patent:
September 29, 2015
Assignee:
BIO PRODUCTS LABORATORY LIMITED
Inventors:
Joan Dalton, Adrian Podmore, Peter Kumpalume
Abstract: The invention relates to methods for the isolation of AAT from solutions containing albumin and AAT using at least two separate metal chelate chromatography steps. The product may be further purified and/or subjected to one or more virus inactivation or reduction steps. The isolated AAT may then be formulated for pharmaceutical use.
Type:
Grant
Filed:
November 29, 2006
Date of Patent:
November 12, 2013
Assignee:
Bio Products Laboratory Limited
Inventors:
Peter Kumpalume, Adrian Podmore, Joan Dalton
Abstract: The present invention relates to processes for the preparation of virus inactivated thrombin, and to the products prepared by these processes.
Type:
Grant
Filed:
July 7, 2003
Date of Patent:
May 7, 2013
Assignee:
Bio Products Laboratory Limited
Inventors:
Caroline Connolly, Christopher Hardway, David Evans, Peter Feldman
Abstract: Abnormal infective prion proteins are removed from liquids containing biologically active substances, particularly blood products, by filtration using a depth filter formed of a matrix comprising solid particles of porous material and having a pore size less than 6 microns. Preferably the filter is free of cationic or anionic charged material.
Type:
Grant
Filed:
January 19, 2000
Date of Patent:
July 24, 2012
Assignee:
Bio Products Laboratory Limited
Inventors:
Anne Gillian Welch, Peter Reynolds Foster